NCT03172689 (CQPiCCO) is a NA clinical trial of CardioQ in Cardiac Output, sponsored by Radboud University Medical Center.

Who is sponsoring NCT03172689?

NCT03172689 is sponsored by Radboud University Medical Center.

What drugs are being tested in NCT03172689?

Interventions in NCT03172689: CardioQ.

What condition does NCT03172689 study?

NCT03172689 studies Cardiac Output.

Is NCT03172689 still recruiting?

NCT03172689 is currently status unknown. Last updated 18 April 2023.

Last reviewed 2023-04-18 · How we verify

NCT03172689: CQPiCCO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Validation of CardioQ Versus PiCCO in Children

Status unknown NA Last updated 18 April 2023

What this trial tests

NA trial testing CardioQ in Cardiac Output in 17 participants. Status unknown.

Timeline

29 August 2017

Primary endpoint
1 December 2023

1 February 2024

Quick facts

Lead sponsor	Radboud University Medical Center
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	17
Start date	29 August 2017
Primary completion	1 December 2023
Estimated completion	1 February 2024
Sites	1 location across Netherlands

Drugs / interventions tested

CardioQ

Conditions studied

Cardiac Output — all drugs for Cardiac Output →

Sponsor

Radboud University Medical Center

Who can join

Adults 3 Months to 18, any sex, with Cardiac Output. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To compare the less invasive Oesophageal Doppler cardiac output Monitor (ODM) to the invasive (standard of care) Transpulmonary Thermodilution cardiac output monitor (TPTD) in children.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cardiac Output

Currently open trials in the same condition.

NCT07082283 — Short-Term Atrial Pacing and Hemodynamics After Cardiac Surgery · NA · recruiting
NCT06551168 — Heat Acclimation in Females · NA · recruiting
NCT06879769 — Optimization of Patient Preparation and Imaging Techniques for Cardiac CT · NA · recruiting
NCT04465201 — The Smart Pump Study · NA · active not recruiting

Other Radboud University Medical Center trials

Trials by the same sponsor.

NCT07485569 — Drug Repurposing in Thyroid Carcinoma: a Feasibility Trial · Phase 1 · not yet recruiting
NCT07514325 — MR-guided Adaptive Stereotactic Radiotherapy for Endometrial Cancer · NA · not yet recruiting
NCT07530263 — Deposition of Inhaled Liposomal Amphotericin B in Chronic Pulmonary Aspergillosis (CPA) · Phase 1 · not yet recruiting
NCT07532577 — Intranasal Insulin to Prevent Intensive Care Unit Delirium · Phase 2, PHASE3 · not yet recruiting
NCT07504172 — Real-world Effectiveness and Dosing Patterns of Tirzepatide in People With Obesity · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03172689 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Radboud University Medical Center
Last refreshed: 18 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03172689.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing